Global Pediatrics Partnering 2010-2016: Deal trends, players
and financials provides comprehensive understanding and unprecedented access to
the pediatrics partnering deals and agreements entered into by the worlds
leading healthcare companies
Description
Global Pediatrics Partnering 2010 to 2016 provides the full
collection of Pediatrics disease deals signed between the world’s
pharmaceutical and biotechnology companies since 2010.
- Trends in Pediatrics partnering deals
- Financial deal terms for headline, upfront and royalty by stage of development
- Pediatrics partnering agreement structure
- Pediatrics partnering contract documents
- Top Pediatrics deals by value
- Most active Pediatrics dealmakers
Most of the deals included within the report occur when a
licensee obtains a right or an option right to license a licensor’s product or
technology. More often these days these deals tend to be multi-component
including both a collaborative R&D and a commercialization of outcomes
element.
The report takes readers through the comprehensive
Pediatrics disease deal trends, key players and top deal values allowing the
understanding of how, why and under what terms companies are currently entering
Pediatrics deals.
The report presents financial deal terms values for
Pediatrics deals, where available listing by overall headline values, upfront
payments, milestones and royalties enabling readers to analyse and benchmark
the value of current deals.
The initial chapters of this report provide an orientation
of Pediatrics dealmaking trends.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in Pediatrics
dealmaking since 2010 covering trends by year, deal type, stage of development,
technology type and therapeutic indication.
Chapter 3 includes an analysis of financial deal terms
covering headline value, upfront payment, milestone payments and royalty rates.
Chapter 4 provides a review of the leading Pediatrics deals
since 2010. Deals are listed by headline value. The chapter includes the top 25
most active Pediatrics dealmakers, together with a full listing of deals to
which they are a party. Where the deal has an agreement contract published at
the SEC a link provides online access to the contract.
Chapter 5 provides comprehensive access to Pediatrics deals
since 2010 where a deal contract is available, providing the user with direct
access to contracts as filed with the SEC regulatory authorities. Each deal
title links via Weblink to an online version of the deal record contract
document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of all
Pediatrics partnering deals by specific Pediatrics target announced since 2010.
The chapter is organized by specific Pediatrics therapeutic target. Each deal
title links via Weblink to an online version of the deal record and where
available, the contract document, providing easy access to each contract
document on demand.
In addition, a comprehensive appendix is provided with each
report of all Pediatrics partnering deals signed and announced since 2010. The
appendices are organized by company A-Z, stage of development at signing, deal
type (collaborative R&D, co-promotion, licensing etc) and technology type.
Each deal title links via Weblink to an online version of the deal record and
where available, the contract document, providing easy access to each contract
document on demand.
The report also includes numerous tables and figures that
illustrate the trends and activities in Pediatrics partnering and dealmaking
since 2010.
In conclusion, this report provides everything a prospective
dealmaker needs to know about partnering in the research, development and
commercialization of Pediatrics technologies and products.
Report scope
Global Pediatrics Partnering 2010 to 2016 is intended to
provide the reader with an in-depth understanding and access to Pediatrics
trends and structure of deals entered into by leading companies worldwide.
Global Pediatrics Partnering 2010 to 2016 includes:
- Trends in Pediatrics dealmaking in the biopharma industry since 2010
- Analysis of Pediatrics deal structure
- Access to headline, upfront, milestone and royalty data
- Access to hundreds of Pediatrics deal contract documents
- Comprehensive access to over 3500 Pediatrics deal records
- The leading Pediatrics deals by value since 2010
- Most active Pediatrics dealmakers since 2010
In Global Pediatrics Partnering 2010 to 2016, available
deals and contracts are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Stage of development at signing
- Deal component type
- Technology type
- Specific therapy indication
The Global Pediatrics Partnering 2010-2016 report provides
comprehensive access to available deals and contract documents for over 200
pediatrics deals. Analyzing actual contract agreements allows assessment of the
following:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are the sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Benefits
Global Pediatrics Partnering 2010 to 2016 provides the
reader with the following key benefits:
- In-depth understanding of Pediatrics deal trends since 2010
- Access Pediatrics deal headline, upfront, milestone and royalty data
- Research hundreds of actual contracts between Pediatrics partner companies
- Comprehensive access to over 750 links to actual Pediatrics deals entered into by the world’s biopharma companies
- Indepth review of Pediatrics deals entered into by the top 25 most active dealmakers
- Benchmark the key deal terms companies have agreed in previous deals
- Identify key terms under which companies partner Pediatrics opportunities
- Uncover companies actively partnering Pediatrics opportunities
Spanning over 500 pages “Global Pediatrics
Partnering 2010-2016: Deal trends, players and financials” report covers Executive
Summary, Introduction, Trends in Pediatrics dealmaking, Financial deal terms
for Pediatrics partnering, Leading Pediatrics deals and dealmakers, Pediatrics
contract document directory, Pediatrics dealmaking by therapeutic target,
Appendices.
For
more information Visit at: http://mrr.cm/33k
Related Reports;
Global Psychiatry Partnering 2010-2016: Deal trends, players
and financials - Visit at - http://mrr.cm/33Z
Global Sexual Health Partnering 2010-2016: Deal trends,
players and financials - Visit at - http://mrr.cm/334
Global Hematology Partnering 2010-2016: Deal trends, players
and financials - Visit at - http://mrr.cm/33o
Global Infectious Diseases Partnering 2010-2016: Deal
trends, players and financials - Visit at - http://mrr.cm/33J
No comments:
Post a Comment
Note: only a member of this blog may post a comment.